DNTH — AI Stock Analysis & Recommendation

TradeFlare's AI research teams rate DNTH a BUY with a conviction of 60/100. The current price is $105.84.

Entry: $102.84
Target: $115.0
Stop: $87.42

The bullish fundamental and sentiment outlook, coupled with a technical oversold bounce signal, suggests a multi-week recovery potential. Catalysts to watch: Positive clinical trial data for claseprubart, a novel C1s inhibitor; Strong analyst consensus with a 'strong_buy' recommendation and high target price; Pipeline advancements and positive news flow driving sentiment. Key risks: Clinical trial failure for product candidates; Significant cash burn rate and potential for future dilution; High risk profile due to pre-revenue status and dependence on drug development.

FlareScore breakdown — Technical: 50 · Fundamental: 85 · Sentiment: 75 · Risk: 20

Frequently asked questions

Is DNTH a buy? TradeFlare's AI currently rates DNTH a BUY with 60/100 conviction.

What is the price target for DNTH? TradeFlare's AI price target for DNTH is $115.0.

Last updated August 29, 2026 · AI-generated analysis for informational purposes, not financial advice.